IL6 and COVID-19: Details of the patient characteristics from the exploratory cohort—including dNLR, the proportion of immature neutrophils, IL-6 levels, and COVID-19 outcomes—are presented in Table 2, enabling a comprehensive visual assessment of the correlations.